DB-1303 is under clinical development by Duality Biologics (Shanghai) and currently in Phase III for Metastatic Breast Cancer. According to GlobalData, Phase III drugs for Metastatic Breast Cancer ...
Some results have been hidden because they may be inaccessible to you